Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Associations between sleep disturbances and diabetes mellitus among blacks with metabolic syndrome: Results from the Metabolic Syndrome Outcome Study (MetSO).

Ramos AR, Wallace DM, Pandi-Perumal SR, Williams NJ, Castor C, Sevick MA, Mcfarlane SI, Jean-Louis G.

Ann Med. 2015 May;47(3):233-7. doi: 10.3109/07853890.2015.1015601. Epub 2015 Apr 9.

PMID:
25856540
2.

Sleep duration and chronic kidney disease: analysis of the national health interview survey.

Salifu I, Tedla F, Pandey A, Ayoub I, Brown C, McFarlane SI, Jean-Louis G.

Cardiorenal Med. 2014 Dec;4(3-4):210-6. doi: 10.1159/000368205. Epub 2014 Oct 17.

3.

Melatonin, the Hormone of Darkness: From Sleep Promotion to Ebola Treatment.

Masters A, Pandi-Perumal SR, Seixas A, Girardin JL, McFarlane SI.

Brain Disord Ther. 2014;4(1). pii: 1000151.

4.

Chronic kidney disease in the elderly: evaluation and management.

Mallappallil M, Friedman EA, Delano BG, McFarlane SI, Salifu MO.

Clin Pract (Lond). 2014;11(5):525-535.

5.

Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base.

Feinman RD, Pogozelski WK, Astrup A, Bernstein RK, Fine EJ, Westman EC, Accurso A, Frassetto L, Gower BA, McFarlane SI, Nielsen JV, Krarup T, Saslow L, Roth KS, Vernon MC, Volek JS, Wilshire GB, Dahlqvist A, Sundberg R, Childers A, Morrison K, Manninen AH, Dashti HM, Wood RJ, Wortman J, Worm N.

Nutrition. 2015 Jan;31(1):1-13. doi: 10.1016/j.nut.2014.06.011. Epub 2014 Jul 16.

6.

Telephone-delivered behavioral intervention among blacks with sleep apnea and metabolic syndrome: study protocol for a randomized controlled trial.

Williams NJ, Jean-Louis G, Brown CD, McFarlane SI, Boutin-Foster C, Ogedegbe G.

Trials. 2014 Jun 12;15:225. doi: 10.1186/1745-6215-15-225.

7.

Linking sleep duration and obesity among black and white US adults.

Donat M, Brown C, Williams N, Pandey A, Racine C, McFarlane SI, Jean-Louis G.

Clin Pract (Lond). 2013 Sep;10(5). doi: 10.2217/cpr.13.47.

8.

Linking sleep to hypertension: greater risk for blacks.

Pandey A, Williams N, Donat M, Ceide M, Brimah P, Ogedegbe G, McFarlane SI, Jean-Louis G.

Int J Hypertens. 2013;2013:436502. doi: 10.1155/2013/436502. Epub 2013 Apr 21.

9.

Hypertension management in the high cardiovascular risk population.

Maraj I, Makaryus JN, Ashkar A, McFarlane SI, Makaryus AN.

Int J Hypertens. 2013;2013:382802. doi: 10.1155/2013/382802. Epub 2013 Feb 6.

10.

Excessive Daytime Sleepiness among Hypertensive US-Born Blacks and Foreign-Born Blacks: Analysis of the CAATCH Data.

Williams N, Abo Al Haija O, Workneh A, Sarpong D, Keku E, Ogedegbe G, McFarlane SI, Jean-Louis G.

Int J Hypertens. 2013;2013:852389. doi: 10.1155/2013/852389. Epub 2013 Jan 28.

11.

Bone Mineral Density as a Predictor of Atherosclerosis and Arterial Wall Stiffness in Obese African-American Women.

McFarlane SI, Qureshi G, Singh G, Venner-Jones K, Salciccioli L, Lazar J.

Cardiorenal Med. 2012 Dec;2(4):328-334. Epub 2012 Nov 24.

12.

The association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation Program.

Saab G, Bomback AS, McFarlane SI, Li S, Chen SC, McCullough PA, Whaley-Connell A; Kidney Early Evaluation Program Investigators.

J Clin Endocrinol Metab. 2012 Dec;97(12):4414-21. doi: 10.1210/jc.2012-2001. Epub 2012 Oct 12.

13.

Narrowed Aortoseptal Angle Is Related to Increased Central Blood Pressure and Aortic Pressure Wave Reflection.

Olafiranye O, Ibrahim M, Kamran H, Venner-Jones K, McFarlane SI, Salciccioli L, Lazar JM.

Cardiorenal Med. 2012 Aug;2(3):177-183. Epub 2012 Jun 7.

14.

High Prevalence of Hypertension and Other Cardiometabolic Risk Factors in US- and Caribbean-Born Blacks with Chest Pain Syndromes.

Bamimore A, Olafiranye O, Demede M, Zizi F, Browne R, Brown C, McFarlane SI, Jean-Louis G.

Cardiorenal Med. 2012 Aug;2(3):163-167.

15.

Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer.

Forte V, Pandey A, Abdelmessih R, Forte G, Whaley-Connell A, Sowers JR, McFarlane SI.

Cardiorenal Med. 2012 May;2(2):143-162. Epub 2012 Apr 18.

16.

Awareness of kidney disease and relationship to end-stage renal disease and mortality.

Whaley-Connell A, Shlipak MG, Inker LA, Kurella Tamura M, Bomback AS, Saab G, Szpunar SM, McFarlane SI, Li S, Chen SC, Norris K, Bakris GL, McCullough PA; Kidney Early Evaluation Program Investigators.

Am J Med. 2012 Jul;125(7):661-9. doi: 10.1016/j.amjmed.2011.11.026. Epub 2012 May 23.

17.

Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program.

Whaley-Connell A, Bomback AS, McFarlane SI, Li S, Roberts T, Chen SC, Collins AJ, Norris K, Bakris GL, Sowers JR, McCullough PA; on behalf of the Kidney Early Evaluation Program Investigators.

Cardiorenal Med. 2011 Jan;1(1):45-52. Epub 2011 Jan 17.

18.

The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease.

Saab G, Whaley-Connell A, Bombeck A, Kurella Tamura M, Li S, Chen SC, McFarlane SI, Sowers JR, Norris K, Bakris GL, McCullough PA; for the Kidney Early Evaluation Program Investigators.

Cardiorenal Med. 2011;1(2):123-130. Epub 2011 Apr 15.

19.

Telmisartan and cardioprotection.

Akhrass PR, McFarlane SI.

Vasc Health Risk Manag. 2011;7:677-83. doi: 10.2147/VHRM.S9447. Epub 2011 Nov 15. Review.

20.

Diabetes mellitus and the risk of cancer.

Pandey A, Forte V, Abdallah M, Alickaj A, Mahmud S, Asad S, McFarlane SI.

Minerva Endocrinol. 2011 Sep;36(3):187-209. Review.

PMID:
22019750
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk